Last week was disappointing. Some have used stronger, more dramatic words, but I think many of us walked around in a bit of a fog.
This edition of “What’s Wrong with This Picture?” highlights a pharmaceutical development company that develops and commercializes anti-inflammatory dietary supplements and drugs. The only revenue
As I sat down to write this piece, it ultimately became part reflection, part snapshot. This next decade is going to be interesting for our
This is year three for TTC’s trend predictions and for the most part they’ve held up (check last year’s here). Developing these is never easy—our
Practically every day there are headlines about a new nutrition study. Some are favorable toward the food item/nutrient/ingredient and some are negative. When the results
There’s a toast that I like to offer up at gatherings of friends and colleagues, and in many ways, it truly sums up how I
A recent Harvard Business Review article reported on a study by researchers at the MIT Sloan School of Management that “found that consumers may be willing
If I’m a lay consumer, I remain absolutely confused and befuddled as dietary supplement brands continue to proliferate, in stores and online. A discerning label
It’s been just over 900 days since Amazon launched their first brand of supplements, Amazon Elements, with only four SKUs. Today, the brand carries 50.
In some of our recent work in the curcumin/turmeric category and emerging prebiotic category we came up against that wall that often faces the dietary
This column has looked at FDA Warning Letters as “must reads” (4/24/2018) and unbelievable reads (6/5/2019), yet a recent FDA Warning Letter to Advanced Botanical